General Information of Drug (ID:
DR4185) |
Drug Name |
OTSSP167
|
Synonyms |
OTSSP 167; OTSSP-167; AMX10201 |
Indication |
Acute myeloid leukaemia
[ICD11: 2A60]
|
Phase 1
|
[1]
|
Breast cancer
[ICD11:
ICD11: 2C60-2C6Y]
|
Phase 1
|
[2]
|
Chronic lymphocytic leukaemia
[ICD11:
ICD11: 2A82]
|
Phase 1
|
[3]
|
Chronic myelogenous leukaemia
[ICD11:
ICD11: 2A20]
|
Phase 1
|
[4]
|
Mantle cell lymphoma
[ICD11:
ICD11: 2A85]
|
Phase 1
|
[5]
|
Myelodysplastic syndrome
[ICD11:
ICD11: 2A37]
|
Phase 1
|
[6]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
487.4 |
Topological Polar Surface Area |
78.4 |
Heavy Atom Count |
33 |
Rotatable Bond Count |
6 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
6 |
Cross-matching ID |
- PubChem CID
- 135398499
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D08FIX
- Formula
- C25H28Cl2N4O2
- Canonical SMILES
- CC(=O)C1=CN=C2C=CC(=NC2=C1NC3CCC(CC3)CN(C)C)C4=CC(=C(C(=C4)Cl)O)Cl
- InChI
- InChI=1S/C25H28Cl2N4O2/c1-14(32)18-12-28-22-9-8-21(16-10-19(26)25(33)20(27)11-16)30-24(22)23(18)29-17-6-4-15(5-7-17)13-31(2)3/h8-12,15,17,33H,4-7,13H2,1-3H3,(H,28,29)
- InChIKey
- DKZYXHCYPUVGAF-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.